跳至主要内容
临床试验/NL-OMON23836
NL-OMON23836已完成不适用

Right parietal inhibition with rTMS in the treatment of depression.

未提供0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • In and outpatients aged between 16 and 65 who met DSM-IV criteria for major depressive episode, and who had a score of 25 or higher on the 10-item Montgomery Asberg Depression Rating Scale (MADRS) were included.

排除标准

  • Exclusion criteria were a history of epilepsy and any other medical disorder that should preclude the administration of rTMS.
  • Only SSRI's, Mirtazapine and Promethazine as psychotropic medication was accepted if the dosage of antidepressive medication had not been changed for 6 weeks, and if the dosage of Promethazine had not been changed for 2 weeks prior to inclusion.
  • Antidepressive medication had to remain stable during the 14 weeks of the study.
  • Furthermore: schizofrenic disorder, a piece if metal in the brain, pacemaker and left-handed patients.

研究者

发起方
未提供

相似试验